If you are prescribed Ranitidine please read the below statement regarding its current status –
In October 2019 the Medicines and Health Care Regulatory Agency (MHRA) issued an alert concerning Zantac (Ranitidine) and recalled all unexpired stock. Subsequently, manufacturers of the generic version of this medication have also decided to stop production pending further investigation of the concerns.
This medication is used to treat conditions such as heartburn and stomach ulcers. There is currently no evidence that medicines in this group have caused any harm to patients, but the MHRA are closely monitoring the situation and we await updates.
If you are prescribed Ranitidine please download the below letter and complete it. Return this to the Health Centre for the attention of the Patient Services Manager.
Chipping Norton Health Centre